Schroder Investment Management Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-23,500
| Closed | -$522K | – | 1167 |
|
2025
Q1 | $522K | Hold |
23,500
| – | – | ﹤0.01% | 1075 |
|
2024
Q4 | $594K | Hold |
23,500
| – | – | ﹤0.01% | 1081 |
|
2024
Q3 | $589K | Hold |
23,500
| – | – | ﹤0.01% | 1092 |
|
2024
Q2 | $551K | Hold |
23,500
| – | – | ﹤0.01% | 1094 |
|
2024
Q1 | $776K | Hold |
23,500
| – | – | ﹤0.01% | 1059 |
|
2023
Q4 | $640K | Sell |
23,500
-40,522
| -63% | -$1.1M | ﹤0.01% | 1061 |
|
2023
Q3 | $1.54M | Sell |
64,022
-92,383
| -59% | -$2.22M | ﹤0.01% | 949 |
|
2023
Q2 | $4.99M | Sell |
156,405
-102,538
| -40% | -$3.27M | 0.01% | 789 |
|
2023
Q1 | $7.93M | Buy |
258,943
+45,156
| +21% | +$1.38M | 0.01% | 686 |
|
2022
Q4 | $8.36M | Buy |
213,787
+3,145
| +1% | +$123K | 0.01% | 670 |
|
2022
Q3 | $10M | Sell |
210,642
-67,862
| -24% | -$3.23M | 0.02% | 610 |
|
2022
Q2 | $11.3M | Buy |
+278,504
| New | +$11.3M | 0.02% | 624 |
|